CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DNLI | Denali Therapeutics INC | Stock-Other | 50.92% | — | — | |
| 2 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 26.99% | — | — | |
| 3 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 12.06% | — | — | |
| 4 | QTRX | Quanterix CORP | Stock-Other | 10.03% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DNLI | Denali Therapeutics INC | +15.6% | — | Unchanged |
| 2 | SYRSEUR | Syros Pharmaceuticals INC | +4.2% | — | Unchanged |
| 3 | QTRX | Quanterix CORP | -1% | — | Unchanged |
| 4 | MCRB1EUR | Seres Therapeutics INC | -5.6% | — | Unchanged |
| 5 | EDIT | Editas Medicine INC | — | EXIT | Sold out |